Metabolic tumor volume—a biomarker derived from PET imaging—can more accurately predict progression-free survival for large B ...

Brazilian researchers have developed an electrochemical sensor that can detect pancreatic cancer in its early stages. The ...

Volastra Therapeutics, a clinical-stage oncology company pioneering therapies targeting chromosomal instability (CIN), today ...

Plasma pTau217 may detect initial buildup of AD-related brain changes before they can be detected by current ‘gold standard’ ...

The Phase II trial enrolled 129 participants, of whom 94% had relapsing remitting multiple sclerosis, and 6% had secondary ...

Ongoing Phase 2 study in metastatic colorectal cancer (mCRC) demonstrates early clinical and biomarker activity with leronlimab in combination ...

A new study suggests that a urine-based biomarker test shows promise in forecasting bladder cancer treatment response, which ...

Medically integrated dispensing improves affordability, adherence, and toxicity management via embedded pharmacy teams, ...

ViewsML, a company building the computational layer for biomarker discovery by transforming tissue analysis from a lab process into software, today announced the completion of an oversubscribed $4.9M ...

Biomarkers are redefining how oncology trials are designed, shifting from single-mutation targeting to comprehensive genomic ...